Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-75
SponsorEye & ENT Hospital of Fudan University

About this trial

To provide a novel therapy idea and method to solve the clinical problem of postoperative adhesion of bilateral vocal cords, patients enrolled in this study will be applied with curcumin on both wound sites of bilateral vocal cords after the surgery on the bilateral vocal cord endoscopically.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with bilateral vocal cord diseases who are going to undergo resection of bilateral vocal cord lesions endoscopically.

Patients with bilateral vocal cord adhesion who are going to undergo incision of bilateral vocal cord adhesion endoscopically.

Disqualifiers

Patients with other laryngeal diseases.

Patients with cardiac and pulmonary insufficiency.

Patients unable to cooperate with the follow-up on time after surgery.

Patients who refuse to sign the informed consent after notification.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Curcumin

    Drug

    Curcumin was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.

  • Mitomycin-C

    Drug

    Mitomycin-C was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: CurcuminExperimental treatment 1 intervention
Group B: MitomycinActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants with laryngeal web formation as assessed by videolaryngoscope

All participants received the videolaryngoscope every month post-surgery, and a laryngeal web is defined as a visible adhesion whose length reached 1 mm or greater.

Time frame
1 year postsurgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.